Analysts expect Ani Pharmaceuticals Inc to report revenue of 294.67 M for Q3 26, against a range of 282.83 M to 306.51 M. The most recent reported quarter, Q2 26, came in at 266.04 M, a 2.7% miss against the 273.51 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 148.33 M | 190.57 M | 197.12 M | 211.37 M | 227.81 M | 247.06 M | 237.46 M | 266.04 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 151.11 M | 174.56 M | 205.07 M | 193.29 M | 244.75 M | 235.06 M | 213.97 M | 294.51 M | 306.51 M | 317.29 M | 295.21 M | 307.87 M | 325.95 M | 393.34 M | 325.92 M | 335.27 M | ||||||||||
| Low Estimate | 131.66 M | 156.82 M | 172.63 M | 165.91 M | 200.30 M | 213.36 M | 181.87 M | 252.51 M | 282.83 M | 283.35 M | 261.98 M | 288.85 M | 305.80 M | 330.05 M | 270.67 M | 303.53 M | ||||||||||
| Consensus Estimate | 141.38 M | 165.69 M | 188.85 M | 179.60 M | 222.52 M | 224.21 M | 197.92 M | 273.51 M | 294.67 M | 300.32 M | 278.59 M | 298.36 M | 315.87 M | 361.70 M | 298.30 M | 319.40 M |
Analysts expect Ani Pharmaceuticals Inc to report earnings per share of 2.13 for Q3 26, against a range of 1.95 to 2.31. The most recent reported quarter, Q2 26, came in at 2.21, a 15.1% beat against the 1.92 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.34 | 1.63 | 1.70 | 1.80 | 2.04 | 2.33 | 2.05 | 2.21 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.13 | 1.62 | 1.42 | 1.50 | 1.81 | 2.06 | 1.47 | 2.10 | 2.31 | 3.25 | 1.83 | 2.53 | 2.90 | 3.64 | 2.66 | 3.08 | ||||||||||
| Low Estimate | 0.93 | 1.36 | 1.18 | 1.38 | 1.49 | 1.84 | 1.23 | 1.74 | 1.95 | 2.81 | 1.65 | 2.21 | 2.56 | 3.08 | 2.28 | 2.80 | ||||||||||
| Consensus Estimate | 1.03 | 1.49 | 1.30 | 1.44 | 1.65 | 1.95 | 1.35 | 1.92 | 2.13 | 3.03 | 1.74 | 2.37 | 2.73 | 3.36 | 2.47 | 2.94 |
Pull Wall Street consensus for Ani Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ANIP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ANIP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ANIP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();